Effect of barley Intake on coronary heart disease risk factor, a randomized controlled trial.
Not Applicable
- Conditions
- Women of aged 50 to 70 years, plasma total cholesterol of 220-280mg/dL, HbA1c of 5.5-6.5%, and without medication for hypertension, hyperlipidemia, and diabetes mellitus.
- Registration Number
- JPRN-C000000081
- Lead Sponsor
- Department of Health Sciences Interdisciplinary Graduate School of medicine and Engineering, University of Ymanashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
cardiovascular disease; psychiatric problem; alcohol consumption >300 g/week; Usually consuming barley products.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome measures were plasma lipids, glucose, weight, and waist. End point was variable change form baseline at 12 weeks.
- Secondary Outcome Measures
Name Time Method Comparison of mean change adjusted baseline value. Test for interaction.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie JPRN-C000000081 barley intake's impact on LDL cholesterol in postmenopausal women with hypercholesterolemia?
How does JPRN-C000000081 barley intervention compare to statins in reducing coronary heart disease risk factors in untreated hypercholesterolemic women?
Which biomarkers, such as HbA1c or CRP, predict response to JPRN-C000000081 barley intake in coronary heart disease risk reduction?
What are the potential adverse events associated with high-dose barley consumption in JPRN-C000000081 participants and their management strategies?
Are there synergistic effects when combining JPRN-C000000081 barley intake with other dietary fibers like psyllium or omega-3 fatty acids for cardiovascular risk factor management?